Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort

被引:0
|
作者
Shekhar Sehgal
Manish Khanolkar
机构
[1] Waikato Hospital,Diabetes and Endocrinology registrar, Department of Endocrinology and Diabetes
[2] Greenlane Clinical Centre,undefined
来源
Diabetes Therapy | 2015年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:99 / 99
相关论文
共 50 条
  • [1] Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort (vol 6, pg 49, 2015)
    Sehgal, Shekhar
    Khanolkar, Manish
    DIABETES THERAPY, 2015, 6 (01) : 99 - 99
  • [2] Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes
    Levin, Philip
    Wei, Wenhui
    Wang, Li
    Pan, Chunshen
    Douglas, Damon
    Baser, Onur
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 439 - 446
  • [3] Insulin pump therapy in type 1 diabetes: a real-world study of mortality and clinical outcomes
    Iqbal, A.
    Haughton, S.
    Riley, D.
    Arshad, M. F.
    Azmi, S.
    Malik, R. A.
    Alam, U.
    DIABETOLOGIA, 2024, 67 : S371 - S371
  • [4] Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
    Davis, Keith L.
    Tangirala, Muralikrishna
    Meyers, Juliana L.
    Wei, Wenhui
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1083 - 1091
  • [5] Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes
    Levin, Philip
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Lin, Jay
    Baser, Onur
    DIABETES, 2012, 61 : A4 - A4
  • [6] Starting insulin in type 2 diabetes: Overcoming barriers to insulin therapy
    Kabadi, Udaya M.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2008, 28 (02) : 65 - 68
  • [7] First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
    Tsai, Shih-Tzer
    Pathan, Faruque
    Ji, Linong
    Yeung, Vincent Tok Fai
    Chadha, Manoj
    Suastika, Ketut
    Son, Hyun Shik
    Tan, Kevin Eng Kiat
    Benjasuratwong, Yupin
    Thy Khue Nguyen
    Iqbal, Farrukh
    JOURNAL OF DIABETES, 2011, 3 (03) : 208 - 216
  • [8] Insulin Pump Therapy in Type 1 Diabetes-a Real-World Study of Mortality and Clinical Outcomes
    Haughton, Sophie
    Riley, David
    Arshad, Muhammad Fahad
    Azmi, Shazli
    Malik, Rayaz A.
    Alam, Uazman
    Iqbal, Ahmed
    DIABETES, 2024, 73
  • [9] Real-World Use of Canagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Harris, Stewart B.
    Reichert, Sonja
    Mequanint, Selam M.
    Spaic, Tamara
    Esler, Jim
    DIABETES, 2017, 66 : A328 - A329
  • [10] Real-World Use of Dapagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Spaic, Tamara
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja
    Miller, Kristina
    DIABETES, 2017, 66 : A327 - A328